Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma Believes In AI, But The Foundation Is Failing
Matt Lowe, chief strategy officer for MasterControl. The pharmaceutical industry's AI market is projected to grow from roughly $4 billion to $25.7 billion by 2030. Despite this surge, medicine makers have yet to see substantially shorter…
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Schott Pharma shares climbed more than 4% in early Frankfurt trading after Barclays upgraded the pharmaceutical packaging company to Overweight, citing improving fundamentals and expectations for accelerating earnings growth. Barclays believes…
XPH vs PJP: Which Pharma ETF Offers Better Value
Invesco Pharmaceuticals ETF (PJP +0.59%) provides a concentrated, low-volatility approach to drug manufacturers, while the State Street SPDR S&P Pharmaceuticals ETF (XPH -0.87%) offers broader sector exposure at a significantly lower annual cost.
Sun Pharma gets favourable verdict in antitrust-litigation in U.S.
Sun Pharmaceutical Industries on Monday (August 17, 2026) said an appellate court in the United States has passed a judgment in favour of the company and its subsidiaries in the antitrust litigation, in the U.S., relating to a 2008 patent…
Kailera Therapeutics: The Record-Breaking Obesity IPO Big Pharma Cannot Ignore
KLRA trades 29% below its IPO high but holds $1.17 billion in cash and carries a $42 analyst consensus price target. Merck's looming Keytruda revenue cliff and Novo Nordisk's need to defend Wegovy dominance make both natural buyers of Kailera's…
Pharma companies seek to block state expansion of discount drug program
(The Center Square) – Multiple drug makers in Illinois are challenging a state law that expands the scope of a federal program under Medicare, arguing Illinois doesn't have the authority to make changes to the program. The federal 340B…
Idea First, Customer Second: The Mindset That Drives Innovation
Nataliya Andreychuk is the CEO of Viseven. She is a leading digital transformation evangelist for the pharma and life sciences industries. After years of conversations with pharmaceutical industry leaders across markets, I've come to a conclusion…
TDs call on pharma company to work with HSE to give access to life-changing drug Skyclarys
FINE GAEL MEMBERS today met with the manufacturers of Skyclarys, a disease-modifying drug for the rare disease Friedreich's Ataxia. Pressure has been mounting on government leaders to intervene and reverse a HSE decision recommending against…
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Consensus Recommendation of 'Moderate Buy' by Analysts
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) has earned an average rating of 'Moderate Buy' from the fourteen ratings firms that are covering the company, MarketBeat reports. One equities research analyst has rated the stock…
Rice Hall James & Associates LLC Purchases Shares of 300,650 Urogen Pharma $URGN
Rice Hall James & Associates LLC purchased a new stake in Urogen Pharma (NASDAQ:URGN - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 300,650 shares of…
The Manufacturers Life Insurance Company Has $196,000 Stock Holdings in Urogen Pharma $URGN
The Manufacturers Life Insurance Company decreased its position in Urogen Pharma (NASDAQ:URGN - Free Report) by 80.4% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 10,909 shares of the…
Indian Stock Market Declines: Crude Oil Spike, US Bond Yields, West Asia Tensions Impact Sentiment
Indian stock markets, including the Sensex and Nifty, opened lower as a significant jump in Brent crude oil prices above $91 per barrel, fuelled by escalating West Asia tensions and rising US bond yields, dampened investor sentiment. Indian…
'Sea Of Red': Futures Slide As Market Wakes Up To Soaring Bond Yields And Diesel Prices
US futures are a 'sea of red' (as Bloomberg describes it) in early trading as thin summer volumes persist, with the wrong kind of inflation coming to the fore and Monday's tech selloff weighing on sentiment despite bullish AI news. The recent…
The startup using AI to help rare disease families develop custom treatments
Nome is building an AI-powered drug development service for ultra-rare disease patients, helping families identify potential treatments and map out a path from diagnosis to clinical development. The startup targets patient groups often overlooked…
Stock Markets decline in early trade as crude oil jumps to $91 per barrel
Market benchmark indices Sensex and Nifty declined in early trade on Tuesday (August 18, 2026) as elevated crude oil prices and rising tensions in West Asia weighed heavily on investors' sentiment. The 30-share BSE Sensex was down 278.32 points to…
Receive a Daily briefing on Pharma Industry News
Get Started